Literature DB >> 1649084

Requirements for SOD mimics operating in vitro to work also in vivo.

G Czapski1, S Goldstein.   

Abstract

When an efficient SOD mimic operating in vitro is introduced into cells, the following requirements are needed in order that this compound will catalyze O2- dismutation efficiently: it should be non toxic, stable, has a long metabolic half life, does not form ternary complexes with the cell components, its reduced form reacts slowly with molecular oxygen, should be able to cross cell membranes and also to reach lipophilic or hydrophobic regions. Thus, it seems that finding an efficient compound that has high SOD-like activity in vivo will not be easily achieved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649084     DOI: 10.3109/10715769109145782

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  5 in total

Review 1.  Is copper pro- or anti-inflammatory? A reconciling view and a novel approach for the use of copper in the control of inflammation.

Authors:  G Berthon
Journal:  Agents Actions       Date:  1993-07

Review 2.  Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems.

Authors:  Jian-Ming Lü; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

Review 3.  Simple biological systems for assessing the activity of superoxide dismutase mimics.

Authors:  Artak Tovmasyan; Julio S Reboucas; Ludmil Benov
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

4.  Synthesis, characterization and potent superoxide dismutase-like activity of novel bis(pyrazole)-2,2'-bipyridyl mixed ligand copper(II) complexes.

Authors:  Andrei S Potapov; Evgenia A Nudnova; Galina A Domina; Liliya N Kirpotina; Mark T Quinn; Andrei I Khlebnikov; Igor A Schepetkin
Journal:  Dalton Trans       Date:  2009-04-07       Impact factor: 4.390

Review 5.  8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.

Authors:  Veda Prachayasittikul; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Drug Des Devel Ther       Date:  2013-10-04       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.